Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access to Olipudase Alfa in France
NCT05359276
·
clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Acid Sphingomyelinase Deficiency (ASMD)
Interventions
DRUG:
Olipudase alfa
Sponsor
Sanofi